Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Colonic Neoplasms 32Rectal Neoplasms 31Colorectal Neoplasms 27Unspecified Adult Solid Tumor, Protocol Specific 15Stomach Neoplasms 10Neoplasm Metastasis 7Lung Neoplasms 6Neuroblastoma 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Burkitt Lymphoma 4Unspecified Childhood Solid Tumor, Protocol Specific 3Sezary Syndrome 3Sarcoma 3Rhabdomyosarcoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

entinostat 2Temozolomide 2Radiotherapy, Conformal 2Magnetic Resonance Spectroscopy 2Irinotecan 2Bevacizumab 2temsirolimus 1etoposide phosphate 1cixutumumab 1carboxyamido-triazole 1adavosertib 1Vorinostat 1Vincristine 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Nivolumab 1Isotretinoin 1Immunoglobulin G 1Disulfides 1Cyclophosphamide 1Congresses as Topic 1Cisplatin 1Carboplatin 1Amplified Fragment Length Polymorphism Analysis 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Pinealoma × Irinotecan × Clear all
NCT02095132 2023-09-26

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1/2 Completed
76 enrolled 25 charts
CNSSarcoma

Medulloblastoma, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive

NCT01217437 2021-07-23

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
108 enrolled 14 charts
CNS

Medulloblastoma, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡